Soleno Therapeutics Inc (SLNO): Analysts Offer Insights on Healthcare Co...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	129
Posts	2150
Boards Moderated	1
Alias Born	12/27/2007

BioSpecialist

Re: None

Thursday, 09/14/2017 8:50:06 AM

Thursday, September 14, 2017 8:50:06 AM

Analysts Offer Insights on Healthcare Companies: Soleno Therapeutics Inc (NASDAQ: SLNO) and Alexion Pharmaceuticals (NASDAQ: ALXN)
http://www.analystratings.com/articles/analysts-offer-insights-on-healthcare-companies-soleno-therapeutics-inc-nasdaq-slno-and-alexion-pharmaceuticals-nasdaq-alxn/#more-502551

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Soleno Therapeutics Inc (NASDAQ: SLNO) and Alexion Pharmaceuticals (NASDAQ: ALXN) with bullish sentiments.

Soleno Therapeutics Inc (NASDAQ: SLNO)

Maxim Group analyst Gabrielle Zhou assigned a Buy rating to Soleno Therapeutics Inc (NASDAQ: SLNO) today and set a price target of $5. The company’s shares opened today at $0.62.

Zhou noted:

“Soleno today announced the issuance of a new patent (9,757,384) from the U.S. Patent and Trademark Office for the use of pharmaceutical formulations of diazoxide and diazaxide choline (Diazoxide Choline Controlled Release Tablet; DCCR) to reduce aggressive behaviors in patients with Prader-Willi syndrome (PWS) or Smith-Magenis syndrome (SMS).”